Latest filing published 23 Jun 2021 for Century Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Aktiengesellschaft Bayer: trading record in brief
Aktiengesellschaft Bayer has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Century Therapeutics, Inc., CRISPR Therapeutics AG and Elanco Animal Health Inc. Over a trading history stretching from 5 January 2018 to 22 June 2021, the count stands at 5 filings.
On the open market, the record shows 2 purchases worth €22.5M and 1 sale worth €1.3B. Sales outweigh purchases by €1.3B. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2021 alone, the filings show 1 purchase and no sales.
The record was last updated on 23 June 2021 with an open-market purchase (€12.6M) in Century Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Aktiengesellschaft Bayer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,390,600 sharesCommon StockSEC:0001209191-21-042752:0
1 of 1 declaration
